MARKET

ARTL

ARTL

Artelo Biosciences Inc
NASDAQ
5.67
-0.28
-4.71%
After Hours: 5.55 -0.12 -2.12% 19:25 04/13 EDT
OPEN
5.71
PREV CLOSE
5.95
HIGH
5.85
LOW
5.08
VOLUME
119.94K
TURNOVER
--
52 WEEK HIGH
85.80
52 WEEK LOW
2.955
MARKET CAP
4.17M
P/E (TTM)
-0.1510
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARTL last week (0406-0410)?
Weekly Report · 20h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 6d ago
Artelo Biosciences files to sell 9.82M shares of common stock for holders
TipRanks · 6d ago
Artelo Biosciences regains Nasdaq listing compliance after equity, annual meeting violations
Reuters · 6d ago
*Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements
Dow Jones · 6d ago
Weekly Report: what happened at ARTL last week (0330-0403)?
Weekly Report · 04/06 09:45
EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank?
Benzinga · 04/02 14:35
3 Penny Stocks to Watch Now, 3/31/26
TipRanks · 03/31 14:13
More
About ARTL
Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company dedicated to the development and commercialization of therapeutics that modulate lipid-signaling pathways. The Company is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, anxiety, dermatologic conditions, pain, and inflammation. Its pipeline products include ART26.12, ART27.13 and ART12.11. ART26.12, its Fatty Acid Binding Protein 5 (FABP5) inhibitor, is being developed as a novel, peripherally acting, non-opioid, non-steroidal analgesic. The Cancer Appetite Recovery Study (CAReS) is a Phase 1/2 randomized, placebo-controlled trial of its clinical program, ART27.13, in patients with cancer anorexia and weight loss. ART12.11, the Company's novel solid-state cannabidiol composition co-formed with tetramethylpyrazine, is targeted for development in anxiety disorders and rare/orphan diseases.

Webull offers Artelo Biosciences Inc stock information, including NASDAQ: ARTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARTL stock methods without spending real money on the virtual paper trading platform.